Sensorion SA (ALSEN.PA)

EUR 0.64

(-6.16%)

Total Liabilities Summary of Sensorion SA

  • Sensorion SA's latest annual total liabilities in 2023 was 13.22 Million EUR , down -22.47% from previous year.
  • Sensorion SA's latest quarterly total liabilities in 2024 Q2 was 18.06 Million EUR , down 0.0% from previous quarter.
  • Sensorion SA reported annual total liabilities of 17.06 Million EUR in 2022, up 13.47% from previous year.
  • Sensorion SA reported annual total liabilities of 15.03 Million EUR in 2021, up 57.85% from previous year.
  • Sensorion SA reported quarterly total liabilities of 13.22 Million EUR for 2023 Q4, down 0.0% from previous quarter.
  • Sensorion SA reported quarterly total liabilities of 17.67 Million EUR for 2023 Q2, down 0.0% from previous quarter.

Annual Total Liabilities Chart of Sensorion SA (2023 - 2011)

Historical Annual Total Liabilities of Sensorion SA (2023 - 2011)

Year Total Liabilities Total Liabilities Growth
2023 13.22 Million EUR -22.47%
2022 17.06 Million EUR 13.47%
2021 15.03 Million EUR 57.85%
2020 9.52 Million EUR -61.72%
2019 24.88 Million EUR 317.68%
2018 5.95 Million EUR 55.06%
2017 3.84 Million EUR 17.86%
2016 3.25 Million EUR -11.91%
2015 3.7 Million EUR 47.11%
2014 2.51 Million EUR 7.83%
2013 2.33 Million EUR 561.52%
2012 352.6 Thousand EUR 67.5%
2011 210.51 Thousand EUR 0.0%

Peer Total Liabilities Comparison of Sensorion SA

Name Total Liabilities Total Liabilities Difference
ABIONYX Pharma SA 6.91 Million EUR -91.367%
ABIVAX Société Anonyme 131.05 Million EUR 89.907%
Adocia SA 31.87 Million EUR 58.496%
Aelis Farma SA 13.08 Million EUR -1.126%
Biophytis S.A. 15.84 Million EUR 16.542%
Advicenne S.A. 24.37 Million EUR 45.739%
genOway Société anonyme 14.45 Million EUR 8.522%
IntegraGen SA 5.97 Million EUR -121.199%
Medesis Pharma S.A. 6.42 Million EUR -105.834%
Neovacs S.A. 3.71 Million EUR -256.326%
NFL Biosciences SA 3.62 Million EUR -265.325%
Plant Advanced Technologies SA 6.78 Million EUR -95.025%
Quantum Genomics Société Anonyme 3.31 Million EUR -299.602%
Theranexus Société Anonyme 5.01 Million EUR -163.692%
TME Pharma N.V. 2.78 Million EUR -374.947%
Valbiotis SA 13.7 Million EUR 3.507%
TheraVet SA 1.48 Million EUR -790.729%
Valerio Therapeutics Société anonyme 20.46 Million EUR 35.376%
argenx SE 402.79 Million EUR 96.716%
BioSenic S.A. 32.26 Million EUR 59.003%
Celyad Oncology SA 9.97 Million EUR -32.564%
DBV Technologies S.A. 38.74 Million USD 65.861%
Galapagos NV 1.56 Billion EUR 99.153%
Genfit S.A. 105.92 Million EUR 87.512%
GeNeuro SA 20.13 Million EUR 34.323%
Hyloris Pharmaceuticals SA 8.61 Million EUR -53.591%
Innate Pharma S.A. 132.29 Million EUR 90.001%
Inventiva S.A. 101.59 Million EUR 86.98%
MaaT Pharma SA 22.46 Million EUR 41.121%
MedinCell S.A. 77.77 Million EUR 82.992%
Nanobiotix S.A. 95.74 Million EUR 86.184%
Onward Medical N.V. 25.69 Million EUR 48.528%
Oryzon Genomics S.A. 25.12 Million EUR 47.355%
OSE Immunotherapeutics SA 59.07 Million EUR 77.611%
Oxurion NV 19.73 Million EUR 32.979%
Pharming Group N.V. 228.28 Million EUR 94.206%
Poxel S.A. 53.9 Million EUR 75.46%
GenSight Biologics S.A. 34.72 Million EUR 61.911%
Transgene SA 26.51 Million EUR 50.118%
Financière de Tubize SA 123.65 Million EUR 89.303%
UCB SA 6.56 Billion EUR 99.798%
Valneva SE 341.14 Million EUR 96.123%
Vivoryon Therapeutics N.V. 4.54 Million EUR -190.901%